BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 28941044)

  • 1. Potential biological targets for bioassay development in drug discovery of Sturge-Weber syndrome.
    Mohammadipanah F; Salimi F
    Chem Biol Drug Des; 2018 Feb; 91(2):359-369. PubMed ID: 28941044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential biological targets for bioassay development in drug discovery of Sturge-Weber syndrome.
    Mohammadipanah F; Salimi F
    Chem Biol Drug Des; 2017 Apr; ():. PubMed ID: 28459499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatic GNAQ Mutation is Enriched in Brain Endothelial Cells in Sturge-Weber Syndrome.
    Huang L; Couto JA; Pinto A; Alexandrescu S; Madsen JR; Greene AK; Sahin M; Bischoff J
    Pediatr Neurol; 2017 Feb; 67():59-63. PubMed ID: 27919468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sturge-Weber syndrome.
    Comi AM
    Handb Clin Neurol; 2015; 132():157-68. PubMed ID: 26564078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sturge-Weber Syndrome: A Review.
    Higueros E; Roe E; Granell E; Baselga E
    Actas Dermosifiliogr; 2017 Jun; 108(5):407-417. PubMed ID: 28126187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.
    Shirley MD; Tang H; Gallione CJ; Baugher JD; Frelin LP; Cohen B; North PE; Marchuk DA; Comi AM; Pevsner J
    N Engl J Med; 2013 May; 368(21):1971-9. PubMed ID: 23656586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sturge-Weber syndrome: an update for the pediatrician.
    Dingenen E; Segers D; De Maeseneer H; Van Gysel D
    World J Pediatr; 2024 May; 20(5):435-443. PubMed ID: 38658498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic GNAQ R183Q mutation is located within the sclera and episclera in patients with Sturge-Weber syndrome.
    Wu Y; Peng C; Huang L; Xu L; Ding X; Liu Y; Zeng C; Sun H; Guo W
    Br J Ophthalmol; 2022 Jul; 106(7):1006-1011. PubMed ID: 33707187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.
    Comi AM; Sahin M; Hammill A; Kaplan EH; Juhász C; North P; Ball KL; Levin AV; Cohen B; Morris J; Lo W; Roach ES;
    Pediatr Neurol; 2016 May; 58():12-24. PubMed ID: 27268758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The somatic GNAQ mutation c.548G>A (p.R183Q) is consistently found in Sturge-Weber syndrome.
    Nakashima M; Miyajima M; Sugano H; Iimura Y; Kato M; Tsurusaki Y; Miyake N; Saitsu H; Arai H; Matsumoto N
    J Hum Genet; 2014 Dec; 59(12):691-3. PubMed ID: 25374402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates on Sturge-Weber Syndrome.
    Yeom S; Comi AM
    Stroke; 2022 Dec; 53(12):3769-3779. PubMed ID: 36263782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features.
    Dompmartin A; van der Vleuten CJM; Dekeuleneer V; Duprez T; Revencu N; Désir J; Te Loo DMWM; Flucke U; Eijkelenboom A; Schultze Kool L; Vikkula M; Boon L
    Eur J Neurol; 2022 Oct; 29(10):3061-3070. PubMed ID: 35715928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis for GNAQ mutations: New insights on the molecular etiology of Sturge-Weber syndrome.
    Martins L; Giovani PA; Rebouças PD; Brasil DM; Haiter Neto F; Coletta RD; Machado RA; Puppin-Rontani RM; Nociti FH; Kantovitz KR
    J Mol Graph Model; 2017 Sep; 76():429-440. PubMed ID: 28779688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GNAQ R183Q somatic mutation contributes to aberrant arteriovenous specification in Sturge-Weber syndrome through Notch signaling.
    Huang L; Sun H; Liu Y; Xu L; Hu M; Yang Y; Wang N; Wu Y; Guo W
    FASEB J; 2023 Sep; 37(9):e23148. PubMed ID: 37606556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRC1 and LYVE1 expressing macrophages in vascular beds of GNAQ p.R183Q driven capillary malformations in Sturge Weber syndrome.
    Nasim S; Bichsel C; Dayneka S; Mannix R; Holm A; Vivero M; Alexandrescu S; Pinto A; Greene AK; Ingber DE; Bischoff J
    Acta Neuropathol Commun; 2024 Mar; 12(1):47. PubMed ID: 38532508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibronectin: characterization of a somatic mutation in Sturge-Weber syndrome (SWS).
    Zhou Q; Zheng JW; Yang XJ; Wang YA; Ye WM; Zhu HG; Zhang ZY
    Med Hypotheses; 2009 Aug; 73(2):199-200. PubMed ID: 19359105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Somatic GNAQ Mutation With Capillary Malformations in a Case of Choroidal Hemangioma.
    Bichsel CA; Goss J; Alomari M; Alexandrescu S; Robb R; Smith LE; Hochman M; Greene AK; Bischoff J
    JAMA Ophthalmol; 2019 Jan; 137(1):91-95. PubMed ID: 30422215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Therapeutic Options in Sturge-Weber Syndrome.
    Comi A
    Semin Pediatr Neurol; 2015 Dec; 22(4):295-301. PubMed ID: 26706016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A child with Apert syndrome and Sturge-Weber syndrome: could fibronectin or the RAS/MAPK signaling pathway be the connection?
    Tan AP; Chong WK
    Childs Nerv Syst; 2018 Jun; 34(6):1247-1250. PubMed ID: 29476210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha in leptomeningeal vascular malformations of Sturge-Weber syndrome.
    Comati A; Beck H; Halliday W; Snipes GJ; Plate KH; Acker T
    J Neuropathol Exp Neurol; 2007 Jan; 66(1):86-97. PubMed ID: 17204940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.